Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions

•Cholera toxin was a potent antigen in components of OMVs purified with deoxycholate.•The LPS content of nOMVs was higher than dOMVs.•Temperature stress 42°C reduced protein content of OMVs of Vibrio cholerae.•Mucosal immunization was able to protect fully against 108 CFU of HI Vibrio cholerae. Chol...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2018-01, Vol.36 (2), p.322-330
Main Authors: Adriani, Rezaei, Mousavi Gargari, Seyed Latif, Nazarian, Shahram, Sarvary, Samaneh, Noroozi, Nafiseh
Format: Article
Language:English
Subjects:
Antigens
Bacteria
Children
Chitosan
Cholera
Developing countries
Encapsulation
Environmental conditions
Gelation
Gram-negative bacteria
Growth conditions
Immunization
Immunogenicity
Infections
Laboratory animals
LDCs
Membrane vesicles
Methods
Mice
Mucosa
Nanoparticles
Neisseria meningitidis
OMVs
Outbreaks
Pathogenesis
Pathogens
Phenols
Protein purification
Proteins
Public health
Tripolyphosphate
Vaccine
Vaccine development
Vaccines
Vesicles
Vibrio cholerae
Virulence
Waterborne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Cholera toxin was a potent antigen in components of OMVs purified with deoxycholate.•The LPS content of nOMVs was higher than dOMVs.•Temperature stress 42°C reduced protein content of OMVs of Vibrio cholerae.•Mucosal immunization was able to protect fully against 108 CFU of HI Vibrio cholerae. Cholera is caused by toxigenic Vibrio cholerae. It is a significant health problem and an important cause of mortality of children in developing countries. Annually, about 5–7 million people are being infected worldwide, leading to death of 100,000 to 120,000. Immunization using the currently available cholera vaccines has been recommended by World Health Organization (WHO) in areas where cholera is endemic or at risk of outbreaks. Gram-negative bacteria secrete outer membrane vesicles (OMVs) that play important roles in virulence and host-pathogen interaction. The content of protein and lipid in OMVs are affected by purification methods and bacterial growth condition. OMVs released from V. cholerae are an appropriate candidate for vaccine development. The protection conferred by a new vaccine candidate prepared using different methods and in two different growth conditions with nanoparticles in an experimental model of cholera in mice was investigated. OMVs were encapsulated in chitosan-tripolyphosphate (TPP) nanoparticles prepared by an ionic gelation method and coated with Eudragit as an enteric polymer. OMVs loaded into nanoparticles (NP-OMVs) were homogeneous and spherical in shape, with a size of 417nm. BALB/c mice (male, 20–24g) were immunized via intraperitoneal (10µg) or oral route (50µg) with free or encapsulated OMVs. Seventy-eight days after first administration, serum of mice was infected with infection dose of V. cholerae (≥107 CFU). The new vaccine was able to protect fully against infection when it was administered via mucosa. By intraperitoneal route, the unpolymerized OMVs increased the protection against these bacteria.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2017.09.004